Last updated on January 2020

A Study of Biomarker-Directed Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)


Find a site near you

Start Over

Umhlanga Oncolgy Center ( Site 2311)

Umhlanga, South Africa
0.87miles
  Connect »